- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03153566
Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients
Comparison Between Tuberculin Vaccine and Cryotherapy in the Treatment of Genital Wart Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Genital warts are highly contagious sexually transmitted diseases (STD) caused by infection of Human Papilloma Virus and, as the most common STD in developed countries, can currently be considered to be globally epidemic.
It is estimated that the frequency of Human Papilloma Virus infection among women in the world ranges from 2% to 44%.
The conventional modalities in treatment of warts include destructive therapies such as salicylic acid, trichloroacetic acid, cryotherapy, silver nitrate, phenol, cantharidin, surgical interventions and laser, antiproliferative agents such as bleomycin, vitamin D analogs, podophyllin, 5 fluorouracil and antiviral agents such as cidofovir and retinoids.
There are different mechanisms have been proposed for the resolution of warts with skin test antigens such as mumps, candida, trichophyton both at the injected as well as distant sites.
Tuberculin:
Purified protein derivative or tuberculin stimulates the cell mediated immunity non specifically by activating T helper 1 cells, Natural Killer cells, and cytokine production an increase in interleukin-12 as a process in boosting the cell-mediated immunity contributes to the mechanism of action.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All types of genital and anal warts will be included in this study especially patients with 5 or more warts and more than 1 cm in size
Exclusion Criteria:
- Patients with immunodeficient diseases or receiving any immunosuppressive drugs
- Pregnancy and lactation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: study group
include (15) patients will be injected with Tuberculin vaccine 0.3 ml every 2 weeks, vaccine will be injected in the largest wart, 4 sessions will be done then patients will be followed for 2 months
|
inject the mother wart with .3
ml tuberculin vaccine every 2 weeks
|
Active Comparator: control group
include (15) patients will be treated with cryotherapy every 2 weeks ,4 sessions will be done then patients will be followed for 2 months
|
10 sec 1 cycle into all genital warts
|
Experimental: combined group
include (15) patients will be treated with combined cryotherapy and Tuberculin vaccine , one week cryotherapy and the other week Tuberculin vaccine , then patients will be followed for 2 weeks
|
inject the mother wart with .3
ml tuberculin vaccine every 2 weeks
10 sec 1 cycle into all genital warts
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
number of patients with complete resolution of genital warts
Time Frame: 4 months
|
frequency (number)
|
4 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 2001 Mar;8(2):209-20. doi: 10.1128/CDLI.8.2.209-220.2001. No abstract available.
- Buck HW Jr. Genital warts. Clin Evid. 2006 Jun;(15):2149-61. No abstract available.
- Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;(31):3-13. doi: 10.1093/oxfordjournals.jncimonographs.a003479.
- Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014 Oct;171(4):696-712. doi: 10.1111/bjd.13310. Epub 2014 Oct 1. No abstract available.
- Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005 May;141(5):589-94. doi: 10.1001/archderm.141.5.589.
- Abd-Elazeim FM, Mohammed GF, Fathy A, Mohamed RW. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen. J Dermatolog Treat. 2014 Jun;25(3):264-7. doi: 10.3109/09546634.2013.768760. Epub 2013 May 6.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PPDG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genital Wart
-
University of Illinois at ChicagoNot yet recruiting
-
Minneapolis Veterans Affairs Medical CenterMinnesota Medical FoundationCompletedPlantar Wart | Wart | Common Wart | Verruca Vulgaris | Verruca PlantarisUnited States
-
Labo'LifeRecruitingPlantar Wart | Common Wart | Flat WartBelgium
-
Karo Pharma ABCompletedPlantar Wart | Common WartPoland
-
Assiut UniversityCompletedPlantar Wart | Common WartEgypt
-
Wayne State UniversitySt Vincent's Hospital; University of California, San Francisco FresnoCompletedWart, Genital
-
Huazhong University of Science and TechnologyCompleted
-
Centro de Investigaciones Medicas y Ensayos Clinicos...CALOX Laboratories; BioanalisisUnknownGenital Wart Virus InfectionNicaragua
-
Ankara City Hospital BilkentCompletedSexual Dysfunction | Genital Wart | Adolescent Development | Sexual Disorder, PhysiologicalTurkey
-
Zagazig UniversityCompletedWarts Hand | Wart, GenitalEgypt
Clinical Trials on tuberculin
-
Statens Serum InstitutCompleted
-
Taichung Veterans General HospitalCenters for Disease Control and Prevention; ChungHwa Veterans house; Taiwan Province...UnknownLatent Tuberculosis | Tuberculosis | Elderly | Tuberculosis ContactChina
-
Assiut UniversityUnknown
-
National Institute of Allergy and Infectious Diseases...Warner Lambert - Parke DavisCompletedHIV Infections | TuberculosisUnited States
-
Statens Serum InstitutCompleted
-
Hospices Civils de LyonTerminatedHealthy | ImmunosuppressedFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingHealthy | Latent Tuberculosis Infection (LTBI)United States
-
Assiut UniversityUnknownCOVID-19 | BCG VaccinationEgypt
-
Harvard University Faculty of MedicineNational Institute of Allergy and Infectious Diseases (NIAID); Brigham and... and other collaboratorsUnknown